These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26383523)

  • 1. Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma.
    Yuan BH; Yuan WP; Li RH; Xiang BD; Gong WF; Li LQ; Zhong JH
    Tumour Biol; 2016 Feb; 37(2):2435-41. PubMed ID: 26383523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
    Guo Z; Xiang B; Zhang J; Jiang J; Li L
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.
    Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH
    PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching.
    Min YW; Lee JH; Gwak GY; Paik YH; Lee JH; Rhee PL; Koh KC; Paik SW; Yoo BC; Choi MS
    J Gastroenterol Hepatol; 2014 May; 29(5):1043-8. PubMed ID: 24863186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study.
    Zhong C; Zhang YF; Huang JH; Xiong CM; Wang ZY; Chen QL; Guo RP
    BMC Cancer; 2018 Jun; 18(1):643. PubMed ID: 29879928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
    Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
    Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.
    Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ
    World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching].
    Ke Y; Zhong J; Guo Z; Liang Y; Li L; Xiang B
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):747-50. PubMed ID: 24844957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
    Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
    Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
    Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
    World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
    Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
    Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.